Watchlist Price Alert

Teladoc Health Inc. (TDOC)

NYSE: TDOC · Real-Time Price · USD

7.14

0.08 (1.13%)

At close: May 05, 2025, 3:59 PM

7.15

0.07%

Pre-market: May 06, 2025, 04:32 AM EDT

1.13% (1D)

Bid	7.06
Market Cap	1.25B
Revenue (ttm)	2.55B
Net Income (ttm)	-1.01B
EPS (ttm)	-5.91
PE Ratio (ttm)	-1.21
Forward PE	-8.29
Analyst	Hold

Ask	7.15
Volume	5,527,468
Avg. Volume (20D)	8,325,655
Open	6.94
Previous Close	7.06
Day's Range	6.86 - 7.27
52-Week Range	6.35 - 15.21
Beta	1.83

About TDOC

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth sol...

Sector Healthcare

IPO Date Jun 30, 2015

Employees 4,620

Stock Exchange NYSE

Ticker Symbol TDOC

Website https://www.teladochealth.com

Full Company Profile

Analyst Forecast

According to 18 analyst ratings, the average rating for TDOC stock is "Hold." The 12-month stock price forecast is $10, which is an increase of 39.96% from the latest price.

Stock Forecasts

Earnings Surprise

Teladoc Health has released their quartely earnings on Apr 30, 2025:

Revenue of $629.4M exceeds estimates by $10.17M, with -2.59% YoY decline.

EPS of -0.19 exceeds estimates by 0.17, with 61.22% YoY growth.

Why Price Moved

2 months ago

+3.99%

Teladoc Health shares are trading higher after the... Unlock content with Pro Subscription

2 months ago

-13.56%

Teladoc shares are trading lower following soft Q1 revenue guidance.

News

2 days ago · seekingalpha.com

Teladoc Health: No Real Rescue In Sight

Teladoc Health needs a turnaround plan, as it lacks a growth catalyst and remains too focused on virtual mental health rather than a revolutionary telehealth technology. The virtual healthcare provide...

5 days ago · seekingalpha.com

Teladoc Health, Inc. (TDOC) Q1 2025 Earnings Call Transcript

Teladoc Health, Inc. (NYSE:TDOC ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Corporate Participants Mike Minchak - Head of Investor Relations Chuck Divita - Chief Executive Officer Mal...

6 days ago · zacks.com

Teladoc (TDOC) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimate...

6 days ago · zacks.com

Teladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates

Teladoc (TDOC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.49 per share a year ago.

6 days ago · zacks.com

Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?

Both HIMS and TDOC are technology-intensive healthcare companies that leverage their strengths in the digital health space to enhance their platforms. Which one is a better investment?

1 week ago · invezz.com

Teladoc stock forms a giant double bottom: will it rise after earnings?

Teladoc Health stock price continues to crash and is hovering at its lowest level on record ahead of its first-quarter earnings. It was trading at $7.16 on Monday, meaning that it has crashed by 21% t...

1 week ago · zacks.com

Unveiling Teladoc (TDOC) Q1 Outlook: Wall Street Estimates for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Teladoc (TDOC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter...

1 week ago · zacks.com

Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why

Teladoc (TDOC) concluded the recent trading session at $7.20, signifying a -0.83% move from its prior day's close.

2 weeks ago · seekingalpha.com

Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade)

Teladoc Health, Inc.'s stock has declined significantly, from a high of $14 per share in February to $7 per share, with ongoing financial struggles and underperformance in key segments. The company re...

3 weeks ago · fool.com

2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction

With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. It's a great strategy, but it's essential to ...

Load More News